4.7 Article

Optimizing the modification density of acid oligopeptides to enhance the bone-targeting activity of liposomes

Journal

COMPOSITES PART B-ENGINEERING
Volume 247, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.compositesb.2022.110288

Keywords

Modification density; Acid oligopeptides; Bone -targeting liposomes; Hydroxyapatite binding; Blood pharmacokinetics

Funding

  1. National Natural Science Foundationof China
  2. National Key R&D Program of China
  3. China Post-doctoral Science Foundation
  4. [82172098]
  5. [81872428]
  6. [81703010]
  7. [82230071]
  8. [2018YFC2001500]
  9. [2016M600342]

Ask authors/readers for more resources

This study systematically investigated the effects of modification density of acid oligopeptides on the bone-targeting activity of liposomes. The results showed that a higher modification density promoted the binding of liposomes to hydroxyapatite, but also increased macrophage-mediated phagocytosis and decreased blood retention. The liposomes with the highest modification density exhibited the strongest bone-targeting activity.
Acid oligopeptide-modified liposomes show promising bone-targeting activity. However, as the modification density of acid oligopeptides increases, liposomes may exhibit stronger hydroxyapatite (HA)-binding activity and decreased blood pharmacokinetics (PK), exerting opposite effects on their bone-targeted delivery. Nowadays, little research has systematically investigated how modification density of acid oligopeptides affects the bone -targeting activity of liposomes. In the present study, we prepared a library of liposomes with identical lipid components and comparable particle sizes but varied modification densities of glutamic hexapeptide (Glu6, a representative of acid oligopeptides). A higher modification density of Glu6 promoted the liposomes binding to HA. In contrast, the high-density Glu6-induced highly negative surface charge stimulated macrophage-mediated phagocytosis of the liposomes, leading to reduced blood retention. Further, biodistribution data revealed that the liposomes with the highest Glu6 density of 5 mol% (5%e-Lip) exerted the strongest bone-targeting activity because their outstanding HA-binding capability completely overcame their reduced blood PK. Moreover, a hemolysis assay showed that the optimized formulation, 5%e-Lip, had good biocompatibility via systemic in-jection. Overall, these results suggest that the higher modification density of acid oligopeptides facilitated stronger bone-targeting activity of the liposomes, providing a basis for the development of efficient bone -targeting liposomal nanoplatforms for bone disease treatment in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available